Provided by Tiger Trade Technology Pte. Ltd.

PepGen Inc.

3.18
+0.06001.92%
Post-market: 3.16-0.0200-0.63%19:57 EDT
Volume:354.29K
Turnover:1.12M
Market Cap:219.79M
PE:-2.67
High:3.30
Open:3.15
Low:3.09
Close:3.12
52wk High:7.80
52wk Low:1.17
Shares:69.12M
Float Shares:36.14M
Volume Ratio:0.65
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1903
EPS(LYR):-2.1234
ROE:-75.45%
ROA:-39.12%
PB:1.84
PE(LYR):-1.50

Loading ...

BUZZ-PepGen falls after US FDA puts partial hold on mid‑stage drug trial

Reuters
·
Mar 05

BRIEF-Pepgen Inc - U.S. FDA Places FREEDOM2 Trial On Partial Clinical Hold Related To Preclinical Pharmacology And Toxicology

Reuters
·
Mar 05

PepGen reports Q4 EPS (27c), consensus (39c)

TIPRANKS
·
Mar 05

PepGen Q4 EPS $(0.27) Beats $(0.36) Estimate

Benzinga Earnings
·
Mar 05

PepGen Inc trading halted, news pending

TIPRANKS
·
Mar 05

PepGen Q4 net loss narrows 17.4% to USD 18.3 million

Reuters
·
Mar 05

BRIEF-PepGen Q4 EPS USD -0.27

Reuters
·
Mar 05

PepGen Q4 Operating Expenses USD 19.705 Million

THOMSON REUTERS
·
Mar 05

Press Release: PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights

Dow Jones
·
Mar 05

FDA places partial clinical hold on PepGen’s FREEDOM2-DM1 trial

Reuters
·
Mar 05

PepGen Inc - Receives Regulatory Clearance to Initiate Freedom2 in South Korea, Australia, and New Zealand

THOMSON REUTERS
·
Mar 05

PepGen Inc: U.S. FDA Places Freedom2 Trial on Partial Clinical Hold Related to Preclinical Pharmacology and Toxicology

THOMSON REUTERS
·
Mar 05

PepGen Inc: Reiterates Guidance for Reporting Data From Freedom2 5 Mg/Kg Cohort in Q1 2026 and From 10 Mg/Kg Cohort in 2H 2026

THOMSON REUTERS
·
Mar 05

NASDAQ TRADE HALT HALT NEWS PENDING AT 04:01 PM

Reuters
·
Mar 05

PepGen CEO James McArthur to Join Fireside Chat at Leerink Global Healthcare Conference

Reuters
·
Mar 03

PepGen Inc : Oppenheimer Initiates Coverage With Outperform Rating; Target Price $15

THOMSON REUTERS
·
Feb 25

PepGen Inc. (PEPG) Receives a New Rating from Oppenheimer

TIPRANKS
·
Feb 25

Analysts Offer Insights on Healthcare Companies: Gossamer Bio (GOSS) and PepGen Inc. (PEPG)

TIPRANKS
·
Feb 25

PepGen Inc expected to post a loss of 35 cents a share - Earnings Preview

Reuters
·
Feb 20

PepGen Is Maintained at Buy by Guggenheim

Dow Jones
·
Feb 18